Abstract
The presence of a high phase I IgG antibody titre may indicate chronic infection and a risk for the transmission of Coxiella burnetii through blood transfusion. The outbreak of Q fever in the Netherlands allowed for the comparison of an enzyme immunoassay (EIA) with the reference immunofluorescence assay (IFA) in a large group of individuals one year after acute Q fever. EIA is 100 % sensitive in detecting high (≥1:1,024) phase I IgG antibody titres. The cost of screening with EIA and confirming all EIA-positive results with IFA is much lower than screening all donations with IFA. This should be taken into account in cost-effectiveness analyses of screening programmes.
Similar content being viewed by others
References
Anonymous (1977) Comment on Q fever transmitted by blood transfusion—United States. Can Dis Wkly Rep 3:210
Kanfer E, Farrag N, Price C, MacDonald D, Coleman J, Barrett AJ (1988) Q fever following bone marrow transplantation. Bone Marrow Transplant 3:165–166
Kruszewska D, Lembowicz K, Tylewska-Wierzbanowska S (1996) Possible sexual transmission of Q fever among humans. Clin Infect Dis 22:1087–1088
Milazzo A, Hall R, Storm PA, Harris RJ, Winslow W, Marmion BP (2001) Sexually transmitted Q fever. Clin Infect Dis 33:399–402
Institut de Veille Sanitaire (2007) Estimation quantitative du risque de contamination d’un don de sang par des agents infectieux (in French). Institut de Veille Sanitaire, Saint-Maurice, France. Available online at: http://www.invs.sante.fr/publications/2007/contamination_sang/rapport_contamination_sang.pdf. Accessed 30 March 2012
Blut A (2005) Coxiella burnetii—pathogen of the Q (Query) fever. Transfus Med Hemother 32:218–226
European Centre for Disease Prevention and Control (ECDC) (2010) Risk assessment on Q fever. ECDC, Stockholm, Sweden. doi:10.2900/28860
Roest HI, Tilburg JJ, van der Hoek W, Vellema P, van Zijderveld FG, Klaassen CH, Raoult D (2011) The Q fever epidemic in The Netherlands: history, onset, response and reflection. Epidemiol Infect 139:1–12
van der Hoek W, Dijkstra F, Schimmer B, Schneeberger PM, Vellema P, Wijkmans C, ter Schegget R, Hackert V, van Duynhoven Y (2010) Q fever in the Netherlands: an update on the epidemiology and control measures. Euro Surveill 15: pii: 19520
Hogema BM, Slot E, Molier M, Schneeberger PM, Hermans MH, van Hannen EJ, van der Hoek W, Cuijpers HT, Zaaijer HL (2012) Coxiella burnetii infection among blood donors during the 2009 Q-fever outbreak in The Netherlands. Transfusion 52:144–150
van der Hoek W, Versteeg B, Meekelenkamp JCE, Renders NH, Leenders AC, Weers-Pothoff I, Hermans MH, Zaaijer HL, Wever PC, Schneeberger PM (2011) Follow-up of 686 patients with acute Q fever and detection of chronic infection. Clin Infect Dis 52:1431–1436
Marmion BP, Storm PA, Ayres JG, Semendric L, Mathews L, Winslow W, Turra M, Harris RJ (2005) Long-term persistence of Coxiella burnetii after acute primary Q fever. QJM 98:7–20
Landais C, Fenollar F, Thuny F, Raoult D (2007) From acute Q fever to endocarditis: serological follow-up strategy. Clin Infect Dis 44:1337–1340
Wegdam-Blans MCA, Kampschreur LM, Delsing CE, Bleeker-Rovers CP, Sprong T, van Kasteren ME, Notermans DW, Renders NH, Bijlmer HA, Lestrade PJ, Koopmans MP, Nabuurs-Franssen MH, Oosterheert JJ; Dutch Q fever Consensus Group (2012) Chronic Q fever: review of the literature and a proposal of new diagnostic criteria. J Infect 64:247–259
Dupont HT, Thirion X, Raoult D (1994) Q fever serology: cutoff determination for microimmunofluorescence. Clin Diagn Lab Immunol 1:189–196
World Health Organization (WHO) (2009) Screening donated blood for transfusion-transmissible infections. WHO, Geneva
Acknowledgements
Bart Versteeg organised the laboratory database.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
van der Hoek, W., Wielders, C.C.H., Schimmer, B. et al. Detection of phase I IgG antibodies to Coxiella burnetii with EIA as a screening test for blood donations. Eur J Clin Microbiol Infect Dis 31, 3207–3209 (2012). https://doi.org/10.1007/s10096-012-1686-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-012-1686-7